Hims & Hers Health reported strong third-quarter revenue growth but swung to a loss and cut its 2026 profitability outlook, according to a BlockBeats report.
Revenue grew as margins weakened
Quarterly revenue rose 49% year over year to $890 million. Gross margin fell to 57% from 74%, while net income moved from a $15.8 million profit to a $33 million loss.
Lower 2026 outlook
The company lowered its adjusted EBITDA forecast for 2026 to $257 million-$277 million from $275 million-$325 million and narrowed full-year revenue guidance to $3.13 billion-$3.15 billion.
Perpetual contract reaction
On Hyperliquid, the HIMS perpetual contract briefly fell to $20.57, about 10.4% below its pre-announcement level of $22.95, before recovering above $23 roughly half an hour later.
Source: BlockBeats English report, published Nov. 10, 2026.